Achieve Life SciencesSTU:SP4P -3.60%32 Market Cap is €550.80 Mil as of Jul. 11, 2026. GuruFocus rates STU:SP4P with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 1,422 Biotechnology companies, Achieve Life Sciences ranks better than 74.19% on this metric.
Achieve Life Sciences's quarterly market cap
increased
from Sep. 2025 (€133.09 Mil) to Dec. 2025 (€194.30 Mil) but then
declined
from Dec. 2025 (€194.30 Mil) to Mar. 2026 (€133.37 Mil).
Achieve Life Sciences's annual market cap
increased
from Dec. 2023 (€76.62 Mil) to Dec. 2024 (€117.76 Mil) and
increased
from Dec. 2024 (€117.76 Mil) to Dec. 2025 (€194.30 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Achieve Life Sciences's Enterprise Value for Today is €538.22 Mil.
Achieve Life Sciences (STU:SP4P) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:SP4P vs STTK, CRMD, EIKN: Market Cap Comparison
For the Biotechnology subindustry, Achieve Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Achieve Life Sciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Achieve Life Sciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Achieve Life Sciences's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achieve Life Sciences (STU:SP4P) has a Market Cap of €550.80 Mil as of Jul. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Achieve Life Sciences and its competitors. According to the industry distribution chart, Achieve Life Sciences ranks #367 out of 1422 companies in the Biotechnology industry, placing it in the top 25.8%.
Is Achieve Life Sciences' Market Cap too high?
Achieve Life Sciences' current Market Cap is €550.80 Mil. Based on the distribution chart, Achieve Life Sciences ranks #367 out of 1422 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Achieve Life Sciences has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Achieve Life Sciences' Market Cap compare to STTK and CRMD?
According to the Biotechnology industry distribution chart, Achieve Life Sciences ranks #367 out of 1422 companies for Market Cap. This puts Achieve Life Sciences in the upper half of its industry. The industry median Market Cap is 120.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 120.54, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Achieve Life Sciences and its competitors. For the Biotechnology industry, the median Market Cap is 120.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Achieve Life Sciences's current Market Cap is €550.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Achieve Life Sciences stock overvalued right now?
Achieve Life Sciences (STU:SP4P) has a current Market Cap of €550.80 Mil. The current Market Cap is €550.80 Mil. Achieve Life Sciences' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Achieve Life Sciences (STU:SP4P), the current Market Cap is €550.80 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
32GF Score
Get the complete analysis for STU:SP4P
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:SP4P has been successfully added to your 
